Publications by authors named "Yaron Rotman"

Claim this Profile
P
Poor Sensitivity of the Fatty Liver Index Among Lean Individuals.
Mohammed Rifat Shaik, Yaron Rotman

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum proteomics of insulin resistance disorders distinguish MASLD from lipodystrophy and insulin receptor defects.
Maria Mironova, Allison Wing, Brent S Abel, Maren C Podszun, Rebecca J Brown, Yaron Rotman

J Clin Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: AASLD Resmetirom Guidance.
Vincent L Chen, Timothy R Morgan, Yaron Rotman, Heather M Patton, Kenneth Cusi

Hepatology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Subtle Iron Deficiency During Vitamin E Treatment For Metabolic Dysfunction-Associated Steatotic Liver Disease.
Maren C Podszun, Ahmad Samer Alawad, Shilpa Lingala, Nevitt Morris, Wen Chun A Huang, Yaron Rotman

J Diet Suppl· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance.
Vincent L Chen, Timothy R Morgan, Yaron Rotman, Heather M Patton, Kenneth Cusi

Hepatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Transient Aminotransferase Elevation is Common With Intrathecal Methotrexate, but Liver Injury is Infrequent.
Harish Gopalakrishna, Julian Hercun, Nirali N Shah, Mark Roschewski, Yaron Rotman

Liver Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance.
Vincent L Chen, Timothy R Morgan, Yaron Rotman, Heather M Patton, Kenneth Cusi

Hepatology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNA production.
Xihui Xu, Rozhin Penjweini, Lóránt Székvölgyi, Zsolt Karányi, Anne-Marie Heckel, Yaron Rotman

Proc Natl Acad Sci U S A· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti

Clin Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-mediated signaling stimulates hepatic glucose production and has a major impact on whole body glucose homeostasis.
Srinivas Pittala, Dhanush Haspula, Yinghong Cui, Won-Mo Yang, Young-Bum Kim, Yaron Rotman

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient elastography.
Harish Gopalakrishna, Gayatri B Nair, Roham Salman Roghani, Natarajan Ravendhran, Yaron Rotman

Eur J Gastroenterol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.
Tingting Yan, Nana Yan, Yangliu Xia, Vorthon Sawaswong, Xinxin Zhu, Yaron Rotman

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated NAFLD.
Rachael J Klein, Gracia M Viana Rodriguez, Yaron Rotman, Rebecca J Brown

Liver Int· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Yaron Rotman

Med Sci Sports Exerc· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutrition Literacy Is Not Sufficient to Induce Needed Dietary Changes in Nonalcoholic Fatty Liver Disease.
Allison M Carroll, Yaron Rotman

Am J Gastroenterol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Breath-Hold 3-Dimensional Magnetic Resonance Elastography Depicts Liver Fibrosis and Inflammation in Obese Patients.
Omar Isam Darwish, Ahmed M Gharib, Sami Jeljeli, Nader S Metwalli, Jenna Feeley, Yaron Rotman

Invest Radiol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease.
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Yaron Rotman

Hepatol Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin treatment rescues CD8 T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.
Simon Wabitsch, Justin D McCallen, Olena Kamenyeva, Benjamin Ruf, John C McVey, Yaron Rotman

J Hepatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD.
Chi Ma, Qiong Fu, Laurence P Diggs, John C McVey, Justin McCallen, Yaron Rotman

Cancer Cell· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.
Thomas J Velenosi, Gil Ben-Yakov, Maren C Podszun, Julian Hercun, Ohad Etzion, Yaron Rotman

Gastroenterology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular Morbidity.
David Yardeni, Ronen Toledano, Victor Novack, Aryeh Shalev, Arik Wolak, Yaron Rotman

J Cardiovasc Pharmacol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty Liver Is an Independent Risk Factor for Delayed Recovery from Anesthesia.
Mark Shapses, Lin Tang, Austin Layne, Andrea Beri, Yaron Rotman

Hepatol Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapy.
Julian Hercun, Grace E Kim, Ben L Da, Yaron Rotman, David E Kleiner

Aliment Pharmacol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease.
Anusha Vittal, Mark Shapses, Bashar Sharma, Disha Sharma, Qian Sun, Yaron Rotman

Hepatol Commun· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological mechanisms and therapeutic targets of fatty liver diseases.
Hua Wang, Wajahat Mehal, Laura E Nagy, Yaron Rotman

Cell Mol Immunol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis